{"disease":{"id":"severe-acute-respiratory-distress-syndrome","name":"severe acute respiratory distress syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03255109","title":"WorldwidE AssessmeNt of Separation of pAtients From Ventilatory assistancE","phase":"","overall_status":"COMPLETED","enrollment_count":11000,"lead_sponsor_name":"European Society of Intensive Care Medicine","has_results":false},{"nct_id":"NCT03415529","title":"Impact of Arterial CO2 Tension on Management and Outcome in Patients With Acute Hypoxemic Respirator Failure and ARDS","phase":"","overall_status":"COMPLETED","enrollment_count":4500,"lead_sponsor_name":"European Society of Intensive Care Medicine","has_results":false},{"nct_id":"NCT04402879","title":"CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals","phase":"NA","overall_status":"UNKNOWN","enrollment_count":596,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT07466524","title":"suPAR Michigan M2C2 Heterogeneity Validation Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"ViroGates A/S","has_results":false},{"nct_id":"NCT04031794","title":"ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT04369469","title":"Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":202,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04987528","title":"Pulmonary Fibrosis During Severe COVID-19 Pneumonia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Hôpital Européen Marseille","has_results":false},{"nct_id":"NCT04402060","title":"A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Apellis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04402957","title":"LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Arch Biopartners Inc.","has_results":true},{"nct_id":"NCT00646152","title":"Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04357730","title":"Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Denver Health and Hospital Authority","has_results":true},{"nct_id":"NCT04745442","title":"Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Maimónides Biomedical Research Institute of Córdoba","has_results":false},{"nct_id":"NCT04333368","title":"Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04935450","title":"Pulmonary Inflammation in COVID-19 ARDS","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Hospital Universitario Ramon y Cajal","has_results":false},{"nct_id":"NCT07558538","title":"Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT05158842","title":"Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT06002841","title":"Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"D'Or Institute for Research and Education","has_results":false},{"nct_id":"NCT04395144","title":"COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Hôpital de Verdun","has_results":false},{"nct_id":"NCT04370834","title":"Tocilizumab for Patients With Cancer and COVID-19 Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04366830","title":"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Mesoblast International Sàrl","has_results":false},{"nct_id":"NCT04657406","title":"Expanded Access to Zofin for Patients With COVID-19","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"ZEO ScientifiX, Inc.","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}